Skip to main content
F
Formulate
Jobs
Companies
Drugs
Advisor
NEW
Insider Intel
Salary
Pricing
Toggle theme
Toggle theme
Menu
argenx Jobs | Formulate
Jobs
argenx
argenx Jobs
Belgium - Zwijnaarde
Biotechnology
argenx is a life sciences company focused on Antibody therapies.
171
open positions at argenx
View Full Profile
Quality Compliance Lead
argenx
Posted 1mo ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Legal
Immunology
Senior
H-1B · 1 FY23
Field Reimbursement Manager - Orlando, FL
argenx
Posted 1mo ago
Orlando
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Oncology
MANAGER
H-1B · 1 FY23
Medical Affairs and Evidence Generation Asset Lead –Executive Director
argenx
Posted 1mo ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Medical Affairs
Immunology
Executive
H-1B · 1 FY23
Director, Regulatory Affairs
argenx
Posted 1mo ago
Remote
$212K - $292K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Regulatory Affairs
Immunology
Executive
H-1B · 1 FY23
Associate Director, Regulatory Affairs
argenx
Posted 1mo ago
Remote
$164K - $226K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Regulatory Affairs
Immunology
Executive
H-1B · 1 FY23
Head of Commercial Analytics & Insights
argenx
Posted 2mo ago
Remote
$236K - $325K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Commercial
Immunology
Executive
H-1B · 1 FY23
Director, Biostatistics and Modeling
argenx
Posted 2mo ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Data Science
Immunology
Executive
H-1B · 1 FY23
Project Toxicologist
argenx
Posted 2mo ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Global DT Lead Development
argenx
Posted 2mo ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Senior
H-1B · 1 FY23
Business Leader, Rocky Plains (Rocky Mountains)
argenx
Posted 2mo ago
United States - Field
$204K - $281K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Business Leader, Southwest (Southwest)
argenx
Posted 2mo ago
United States - Field
$204K - $281K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Market Head (Regional General Manager) - Florida & Puerto Rico
argenx
Posted 2mo ago
United States - Field
$236K - $325K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
EXECUTIVE
H-1B · 1 FY23
Business Leader, Mid-Atlantic (Mid-Atlantic)
argenx
Posted 2mo ago
United States - Field
$204K - $281K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Business Leader, Los Angeles
argenx
Posted 2mo ago
United States - Field
$204K - $281K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Business Leader, Southeast (North Carolina & Virginia)
argenx
Posted 2mo ago
United States - Field
$204K - $281K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Market Head (Regional General Manager) - South Central
argenx
Posted 2mo ago
United States - Field
$236K - $325K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
EXECUTIVE
H-1B · 1 FY23
Market Head (Regional General Manager) - Midwest
argenx
Posted 2mo ago
United States - Field
$236K - $325K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
EXECUTIVE
H-1B · 1 FY23
Business Leader, Great Lakes (Michigan)
argenx
Posted 2mo ago
United States - Field
$204K - $281K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Business Leader, Northeast (New England)
argenx
Posted 2mo ago
United States - Field
$204K - $281K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Neurology
MID
H-1B · 1 FY23
Trial Operations Excellence & Innovation Lead
argenx
Posted 2mo ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Senior
H-1B · 1 FY23
Previous
1
More pages
7
8
9
Next
Company Overview
Active Jobs
171
Pipeline Programs
88
Drug Products
2
Clinical Trials
91
View Full Company Profile
Therapeutic Areas
Neurology
Immunology
Oncology
Links
Company Website
Careers Page
Hematology
Rare Diseases